Global IP Strategy Director & Counsel

Jazz Pharmaceuticals, Inc.; California (PA); Hybrid; USD 259,000 - 389,000; Full time

Benefits offered by this job

Remote work

Competitive compensation

Benefits package

Job summary

Jazz Pharmaceuticals, Inc. seeks a Senior Director, Corporate Counsel, IP, to lead global patent and IP strategies for its innovative biopharma portfolio.

You will shape patent strategy across internal discoveries, acquisitions, and collaborations, aligning with growth plans and maximizing asset value. You will advise senior leadership, manage external counsel, and drive due diligence, portfolio development, and integration efforts to protect Jazz's competitive position in oncology and

Qualifications

• Qualified U.S. Patent Attorney or Agent with 10+ years in biopharma IP.
• Experience in corporate development, licensing, and M&A.
• Expertise in freedom-to-operate, exclusivity, and portfolio management.
• Ability to influence executives and manage external counsel.

Responsibilities

• Lead IP diligence for acquisitions, licensing, collaborations, and partnerships.
• Develop and execute global patent strategies for asset value.
• Oversee lifecycle management from invention capture to issuance.
• Advise on transaction documents and integration provisions.
• Coach cross-functional teams and interact with executives.

Skills

U.S. Patent Attorney/Agent

IP due diligence

Portfolio development

Acquisitions & licensing

Strategic advisory

Cross-functional collaboration

Patent prosecution management

Education

Undergraduate degree in biological sciences

Advanced degree preferred

Job description

Jazz Pharmaceuticals, Inc. seeks a Senior Director, Corporate Counsel, IP, to lead global patent and IP strategies for its innovative biopharma portfolio.

You will shape patent strategy across internal discoveries, acquisitions, and collaborations, aligning with growth plans and maximizing asset value. You will advise senior leadership, manage external counsel, and drive due diligence, portfolio development, and integration efforts to protect Jazz's competitive position in oncology and